1. Home
  2. OPAL vs ACET Comparison

OPAL vs ACET Comparison

Compare OPAL & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

HOLD

Current Price

$2.61

Market Cap

78.3M

Sector

Utilities

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.50

Market Cap

93.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
ACET
Founded
1998
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.3M
93.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OPAL
ACET
Price
$2.61
$0.50
Analyst Decision
Sell
Buy
Analyst Count
4
4
Target Price
$2.81
$8.50
AVG Volume (30 Days)
191.5K
2.1M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$329,243,000.00
N/A
Revenue This Year
$17.15
N/A
Revenue Next Year
$22.04
N/A
P/E Ratio
$112.28
N/A
Revenue Growth
7.26
N/A
52 Week Low
$1.26
$0.45
52 Week High
$4.08
$1.11

Technical Indicators

Market Signals
Indicator
OPAL
ACET
Relative Strength Index (RSI) 58.14 33.42
Support Level $2.50 $0.50
Resistance Level $2.74 $0.59
Average True Range (ATR) 0.15 0.05
MACD 0.03 0.00
Stochastic Oscillator 79.34 3.28

Price Performance

Historical Comparison
OPAL
ACET

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: